Literature DB >> 23822654

Toward patient-centered drug development in oncology.

Ethan Basch1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23822654     DOI: 10.1056/NEJMp1114649

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  41 in total

1.  Radiopharmaceutical therapy in the era of precision medicine.

Authors:  George Sgouros; David M Goldenberg
Journal:  Eur J Cancer       Date:  2014-06-19       Impact factor: 9.162

Review 2.  The Value of Patient Reported Outcomes and Other Patient-Generated Health Data in Clinical Hematology.

Authors:  Hemant S Murthy; William A Wood
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

Review 3.  Legal and regulatory considerations associated with use of patient-generated health data from social media and mobile health (mHealth) devices.

Authors:  C Petersen; P DeMuro
Journal:  Appl Clin Inform       Date:  2015-01-14       Impact factor: 2.342

4.  Inconsistent conclusions on QoL outcomes from the same clinical trial.

Authors:  Stefan Lange; Jan Gaertner; Natalie McGauran; Nobert Schmacke; Vera Weingärtner
Journal:  Gastric Cancer       Date:  2015-04-18       Impact factor: 7.370

5.  The Complementary Nature of Patient-Reported Outcomes and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591).

Authors:  Pamela J Atherton; Deborah W Watkins-Bruner; Carolyn Gotay; Carol M Moinpour; Daniel V Satele; Kathryn A Winter; Paul L Schaefer; Benjamin Movsas; Jeff A Sloan
Journal:  J Pain Symptom Manage       Date:  2015-05-30       Impact factor: 3.612

6.  Cancer patients' preferences for therapy decisions can be grouped into categories and separated by demographic factors.

Authors:  Jana Arnholdt; Jörg Haier
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-30       Impact factor: 4.553

Review 7.  Integration of Patient Reported Outcomes in Drug Development in Genitourinary Cancers.

Authors:  Risa L Wong; Alicia K Morgans
Journal:  Curr Oncol Rep       Date:  2020-02-08       Impact factor: 5.075

Review 8.  Outcome assessments in rheumatoid arthritis.

Authors:  Katarzyna Gilek-Seibert; Kara Prescott; Salahuddin Kazi
Journal:  Curr Rheumatol Rep       Date:  2013-11       Impact factor: 4.592

Review 9.  Depression screening in patients with brain tumors: a review.

Authors:  Aiste Pranckeviciene; Adomas Bunevicius
Journal:  CNS Oncol       Date:  2015

10.  Long-term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high-risk prostate cancer.

Authors:  Jonathan L Silberstein; Stephen A Poon; Daniel D Sjoberg; Alexandra C Maschino; Andrew J Vickers; Aaron Bernie; Badrinath R Konety; W Kevin Kelly; James A Eastham
Journal:  BJU Int       Date:  2015-04-17       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.